{"id":"https://openalex.org/W4365514092","doi":"https://doi.org/10.1158/1538-7445.am2023-ct022","title":"Abstract CT022: Five-year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the phase II L-MIND study","display_name":"Abstract CT022: Five-year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the phase II L-MIND study","publication_year":2023,"publication_date":"2023-04-14","ids":{"openalex":"https://openalex.org/W4365514092","doi":"https://doi.org/10.1158/1538-7445.am2023-ct022"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-ct022","doi":"https://doi.org/10.1158/1538-7445.am2023-ct022","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-ct022","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061317839","display_name":"Johannes Duell","orcid":"https://orcid.org/0000-0001-6935-7997","observed_orcids":["https://orcid.org/0000-0001-6935-7997"]},"institutions":[{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Johannes Duell","raw_affiliation_strings":["1Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum W\u00fcrzburg, W\u00fcrzburg, Germany;","institution_ids":["https://openalex.org/I4210126310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007117385","display_name":"Pau Abrisqueta","orcid":"https://orcid.org/0000-0001-9625-7422","observed_orcids":["https://orcid.org/0000-0001-9625-7422","https://orcid.org/0000-0003-3028-7500"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pau Abrisqueta","raw_affiliation_strings":["2Department of Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron University Hospital, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematology, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron University Hospital, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077504536","display_name":"Marc P.E. Andr\u00e9","orcid":"https://orcid.org/0000-0001-7101-810X","observed_orcids":["https://orcid.org/0000-0001-7101-810X"]},"institutions":[{"id":"https://openalex.org/I4210093617","display_name":"CHU Dinant Godinne UCL Namur","ror":"https://ror.org/00ntbvq76","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210093617"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marc Andre","raw_affiliation_strings":["3Department of Hematology, CHU UCL Namur, Yvoir, Belgium;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Hematology, CHU UCL Namur, Yvoir, Belgium;","institution_ids":["https://openalex.org/I4210093617"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031158730","display_name":"Marinela Augustin","orcid":"https://orcid.org/0000-0003-0494-0422","observed_orcids":["https://orcid.org/0000-0003-0494-0422"]},"institutions":[{"id":"https://openalex.org/I27945538","display_name":"Paracelsus Medical University","ror":"https://ror.org/03z3mg085","country_code":"AT","type":"education","lineage":["https://openalex.org/I27945538"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Marinela Augustin","raw_affiliation_strings":["4Department of Hematology and Oncology, Klinikum Nuernberg, Paracelsus Medical University, Nuernberg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematology and Oncology, Klinikum Nuernberg, Paracelsus Medical University, Nuernberg, Germany;","institution_ids":["https://openalex.org/I27945538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041745367","display_name":"Gianluca Ga\u00efdano","orcid":"https://orcid.org/0000-0002-4681-0151","observed_orcids":["https://orcid.org/0000-0002-4681-0151"]},"institutions":[{"id":"https://openalex.org/I123338534","display_name":"Universit\u00e0 degli Studi del Piemonte Orientale \u201cAmedeo Avogadro\u201d","ror":"https://ror.org/04387x656","country_code":"IT","type":"education","lineage":["https://openalex.org/I123338534"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluca Gaidano","raw_affiliation_strings":["5Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy;","institution_ids":["https://openalex.org/I123338534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048566051","display_name":"Eva M. Gonz\u00e1lez-Barca","orcid":"https://orcid.org/0000-0002-1323-1508","observed_orcids":["https://orcid.org/0000-0002-1323-1508"]},"institutions":[{"id":"https://openalex.org/I4210087039","display_name":"Institut d'Investigaci\u00f3 Biom\u00e9dica de Bellvitge","ror":"https://ror.org/0008xqs48","country_code":"ES","type":"facility","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050225","https://openalex.org/I4210087039","https://openalex.org/I4210096656","https://openalex.org/I4210106543","https://openalex.org/I4210107147","https://openalex.org/I4210153292","https://openalex.org/I4387153040","https://openalex.org/I71999127"]},{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210143012","display_name":"Duran i Reynals Hospital","ror":"https://ror.org/03qwghy04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210143012"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Eva Gonz\u00e1lez Barca","raw_affiliation_strings":["6Institut Catal\u00e0 d'Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Institut Catal\u00e0 d'Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210087039","https://openalex.org/I4210107147","https://openalex.org/I4210143012","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102788725","display_name":"Wojciech J. Jurczak","orcid":"https://orcid.org/0000-0003-1879-8084","observed_orcids":["https://orcid.org/0000-0003-1879-8084"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Wojciech Jurczak","raw_affiliation_strings":["7Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krak\u00f3w, Poland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krak\u00f3w, Poland;","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014125875","display_name":"Nagesh Kalakonda","orcid":"https://orcid.org/0000-0002-5300-1360","observed_orcids":["https://orcid.org/0000-0002-5300-1360"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nagesh Kalakonda","raw_affiliation_strings":["8Department of Molecular and Clinical Cancer University of Liverpool, Liverpool, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Department of Molecular and Clinical Cancer University of Liverpool, Liverpool, United Kingdom;","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071466957","display_name":"Anna Marina Liberati","orcid":"https://orcid.org/0000-0002-3686-3188","observed_orcids":["https://orcid.org/0000-0002-3686-3188"]},"institutions":[{"id":"https://openalex.org/I27483092","display_name":"University of Perugia","ror":"https://ror.org/00x27da85","country_code":"IT","type":"education","lineage":["https://openalex.org/I27483092"]},{"id":"https://openalex.org/I4210123105","display_name":"Azienda Ospedaliera S.Maria","ror":"https://ror.org/02t96cy48","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210123105"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Marina Liberati","raw_affiliation_strings":["9Universit\u00e0 degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Universit\u00e0 degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy;","institution_ids":["https://openalex.org/I27483092","https://openalex.org/I4210123105"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I2802841970","display_name":"The Ohio State University Wexner Medical Center","ror":"https://ror.org/00c01js51","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kami J. Maddocks","raw_affiliation_strings":["10Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH;","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I2802841970","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074570151","display_name":"Tobias Menne","orcid":"https://orcid.org/0000-0002-3289-2344","observed_orcids":["https://orcid.org/0000-0002-3289-2344"]},"institutions":[{"id":"https://openalex.org/I2801663869","display_name":"Newcastle upon Tyne Hospitals NHS Foundation Trust","ror":"https://ror.org/05p40t847","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801663869"]},{"id":"https://openalex.org/I2801924861","display_name":"Freeman Hospital","ror":"https://ror.org/00cdwy346","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801663869","https://openalex.org/I2801924861"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Tobias Menne","raw_affiliation_strings":["11Freeman Hospital, The Newcastle upon Tyne Hospitals, NHS Foundation Trust, Newcastle upon Tyne, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Freeman Hospital, The Newcastle upon Tyne Hospitals, NHS Foundation Trust, Newcastle upon Tyne, United Kingdom;","institution_ids":["https://openalex.org/I2801663869","https://openalex.org/I2801924861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085356385","display_name":"Zsolt Nagy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Zsolt Nagy","raw_affiliation_strings":["12Semmelweis University, Budapest, Hungary;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Semmelweis University, Budapest, Hungary;","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052071966","display_name":"Olivier Tournilhac","orcid":"https://orcid.org/0000-0002-9438-621X","observed_orcids":["https://orcid.org/0000-0002-9438-621X"]},"institutions":[{"id":"https://openalex.org/I4210128870","display_name":"Centre Hospitalier Universitaire de Clermont-Ferrand","ror":"https://ror.org/02tcf7a68","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128870"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Olivier Tournilhac","raw_affiliation_strings":["13CHU de Clermont-Ferrand, Lyon, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13CHU de Clermont-Ferrand, Lyon, France;","institution_ids":["https://openalex.org/I4210128870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036001420","display_name":"Abhishek Bakuli","orcid":"https://orcid.org/0000-0001-5123-1974","observed_orcids":["https://orcid.org/0000-0001-5123-1974"]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Abhishek Bakuli","raw_affiliation_strings":["14MorphoSys AG, Planegg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14MorphoSys AG, Planegg, Germany;","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011014349","display_name":"Aasim Amin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Aasim Amin","raw_affiliation_strings":["14MorphoSys AG, Planegg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14MorphoSys AG, Planegg, Germany;","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053541010","display_name":"Konstantin Gurbanov","orcid":"https://orcid.org/0009-0000-1191-6055","observed_orcids":["https://orcid.org/0009-0000-1191-6055"]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Konstantin Gurbanov","raw_affiliation_strings":["14MorphoSys AG, Planegg, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14MorphoSys AG, Planegg, Germany;","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086354986","display_name":"Gilles A. Salles","orcid":"https://orcid.org/0000-0002-9541-8666","observed_orcids":["https://orcid.org/0000-0002-9541-8666"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gilles Salles","raw_affiliation_strings":["15Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":10,"institutions_distinct_count":23,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"8_Supplement","first_page":"CT022","last_page":"CT022"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00419999985024333,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tafasitamab","display_name":"tafasitamab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapsed-refractory-diffuse-large-b-cell-lymphoma","display_name":"relapsed/refractory diffuse large B-cell lymphoma","score":0.906000018119812},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.8939999938011169},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8619999885559082},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.5189999938011169},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7440000176429749},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9710000157356262},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.7300000190734863},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7020000219345093},{"id":"https://openalex.org/keywords/prior-lines-of-therapy","display_name":"prior lines of therapy","score":0.6660000085830688},{"id":"https://openalex.org/keywords/5-year-follow-up","display_name":"five-year follow-up","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7951996326446533},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.6868276596069336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6501163244247437},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5831145644187927},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5733175277709961},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5150741934776306},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4905321002006531},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.46895831823349},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.46511274576187134},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4448878765106201},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4387570321559906},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.4278075397014618},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3580472469329834},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3511717915534973},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.29921776056289673},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.27634501457214355},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.2102769911289215},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.19919556379318237},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18762320280075073},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-ct022","doi":"https://doi.org/10.1158/1538-7445.am2023-ct022","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-ct022","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386271179","https://openalex.org/W4385702668","https://openalex.org/W3112732938","https://openalex.org/W4379334852","https://openalex.org/W4386271804","https://openalex.org/W3172444569","https://openalex.org/W4386281972","https://openalex.org/W4310127427","https://openalex.org/W4386102498","https://openalex.org/W4296468505"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Tafasitamab,":[2],"an":[3],"anti-CD19":[4],"immunotherapy":[5,432],"that":[6,430,437],"enhances":[7],"antibody-dependent":[8],"cellular":[9],"cytotoxicity":[10],"and":[11,19,109,172,174,217,229,256,287,295,315,330,355,366,485,521],"phagocytosis,":[12],"received":[13],"accelerated":[14],"approval":[15],"in":[16,22,24,123,273,305,394,441,489],"the":[17,51,54,79,227,306,418,499,508],"USA":[18],"conditional":[20],"authorization":[21],"Europe":[23],"combination":[25,124,362,387],"with":[26,32,97,125,211,226,238,277,292,297,301,322,352,368,383,396,402,422,491],"lenalidomide":[27],"(LEN)":[28],"for":[29,43,118,340,347,400,511],"patients":[30,490],"(pts)":[31],"relapsed":[33,492],"or":[34,136,151,493],"refractory":[35,494],"(R/R)":[36],"diffuse":[37],"large":[38],"B-cell":[39],"lymphoma":[40],"(DLBCL)":[41],"ineligible":[42,399],"autologous":[44],"stem":[45],"cell":[46],"transplant":[47],"(ASCT)":[48],"based":[49],"on":[50],"results":[52,497],"of":[53,83,163,176,188,206,213,219,243,280,377,487,507],"open-label,":[55],"multicenter,":[56],"single-arm,":[57],"Phase":[58],"II":[59,501],"L-MIND":[60,378,502],"study":[61,503],"(NCT02399085;":[62],"Salles":[63],"G,":[64],"et":[65,72],"al.":[66,73],"Lancet":[67],"Oncol":[68],"2020,":[69],"Duell":[70],"J,":[71],"Haematologica":[74],"2021).":[75],"Here,":[76],"we":[77],"report":[78],"final,":[80,374],"5-year":[81,375],"follow-up":[82],"L-MIND.":[84],"Data":[85],"cut-off":[86],"was":[87,116,142,223,234,249,259,270,337],"Nov":[88],"14,":[89],"2022.":[90],"Methods:":[91],"Pts":[92,300],"were":[93,197,350,415],"aged":[94],"\u226518":[95],"years":[96],"ASCT-ineligible":[98],"R/R":[99,397],"DLBCL,":[100],"1-3":[101],"prior":[102,186],"systemic":[103],"therapies":[104],"(including":[105],"a":[106],"CD20-targeting":[107],"regimen),":[108],"ECOG":[110],"PS":[111],"0-2.":[112],"Tafasitamab":[113],"(12":[114],"mg/kg)":[115],"given":[117],"up":[119,241],"to":[120,320,363],"12":[121],"cycles":[122],"LEN":[126,386],"(25":[127],"mg),":[128],"then":[129],"as":[130],"monotherapy":[131,365,369],"until":[132],"disease":[133,286],"progression":[134],"(PD)":[135],"unacceptable":[137],"toxicity.":[138],"The":[139,203,373],"primary":[140,228],"endpoint":[141],"best":[143,278],"objective":[144],"response":[145,149,153,164,279],"rate":[146],"(ORR;":[147],"complete":[148],"[CR]":[150],"partial":[152],"[PR],":[154],"by":[155,185,390],"independent":[156],"radiology":[157],"committee).":[158],"Secondary":[159],"endpoints":[160,184],"included":[161],"duration":[162],"(DoR),":[165],"progression-free":[166],"survival":[167,170],"(PFS),":[168],"overall":[169],"(OS),":[171],"incidence":[173,357],"severity":[175],"adverse":[177],"events":[178],"(AEs).":[179],"Exploratory":[180],"analyses":[181],"evaluated":[182],"efficacy":[183,346,484],"lines":[187],"therapy":[189],"(pLoT).":[190],"Results:":[191],"Of":[192],"81":[193],"pts":[194,275,321,395],"enrolled,":[195],"80":[196],"treated":[198],"(full":[199],"analysis":[200,376],"set":[201],"[FAS]).":[202],"ORR":[204,310],"(FAS)":[205],"57.5%":[207],"[95%":[208],"CI:":[209],"45.9-68.5],":[210],"CR":[212,313,328],"41.2%":[214],"[30.4-51.6]":[215],"(n=33)":[216],"PR":[218,317,332],"16.2%":[220],"[8.9-26.2]":[221],"(n=13),":[222],"generally":[224],"consistent":[225,351],"3-year":[230],"analyses.":[231],"Median":[232,247],"DoR":[233,336,404],"not":[235,338,405],"reached":[236,339,406],"(NR)":[237],"median":[239,257,335,403],"follow":[240],"(mFU)":[242],"44.0":[244],"months":[245,251,261,272,409],"[29.9-57.0].":[246],"PFS":[248],"11.6":[250],"[5.7-45.7]":[252],"(mFU":[253,263],"45.6":[254],"[22.9-57.6])":[255],"OS":[258,269],"33.5":[260],"[18.3-NR]":[262],"65.6":[264],"[59.9-70.3]).":[265],"At":[266],"data":[267,424,428],"cut-off,":[268],">60":[271],"21":[274],"(18":[276],"CR,":[281],"1":[282,284,288,293,302],"PR,":[283],"stable":[285],"PD),":[289],"including":[290],"14":[291],"pLoT":[294,303,324],"7":[296],"\u22652":[298,323],"pLoT.":[299],"(n=40)":[304],"FAS":[307],"had":[308],"higher":[309],"(67.5%;":[311],"52.5%":[312],"[n=21]":[314],"15%":[316],"[n=6])":[318],"compared":[319],"(n=40;":[325],"47.5%;":[326],"30%":[327],"[n=12]":[329],"17.5%":[331],"[n=7]).":[333],"However,":[334],"both":[341],"subgroups,":[342],"indicating":[343],"similar":[344],"long-term":[345,391,427],"responders.":[348],"AEs":[349],"previous":[353],"reports":[354],"manageable;":[356],"declined":[358],"after":[359,407],"transition":[360],"from":[361,498],"tafasitamab":[364,384,392,488],"again":[367],">2":[370],"years.":[371],"Conclusion:":[372],"showed":[379],"prolonged":[380],"durable":[381],"responses":[382],"+":[385],"therapy,":[388],"followed":[389],"monotherapy,":[393],"DLBCL":[398],"ASCT,":[401],"44":[408],"mFU.":[410],"No":[411],"new":[412],"safety":[413,486],"signals":[414],"identified,":[416],"confirming":[417],"tolerability":[419],"profile":[420],"observed":[421],"earlier":[423],"cuts.":[425],"These":[426],"suggest":[429],"this":[431],"may":[433],"have":[434],"curative":[435],"potential":[436],"is":[438],"being":[439],"explored":[440],"further":[442],"studies.":[443],"Citation":[444],"Format:":[445],"Johannes":[446],"Duell,":[447],"Pau":[448],"Abrisqueta,":[449],"Marc":[450],"Andre,":[451],"Marinela":[452],"Augustin,":[453],"Gianluca":[454],"Gaidano,":[455],"Eva":[456],"Gonz\u00e1lez":[457],"Barca,":[458],"Wojciech":[459],"Jurczak,":[460],"Nagesh":[461],"Kalakonda,":[462],"Anna":[463],"Marina":[464],"Liberati,":[465],"Kami":[466],"J.":[467],"Maddocks,":[468],"Tobias":[469],"Menne,":[470],"Zsolt":[471],"Nagy,":[472],"Olivier":[473],"Tournilhac,":[474],"Abhishek":[475],"Bakuli,":[476],"Aasim":[477],"Amin,":[478],"Konstantin":[479],"Gurbanov,":[480],"Gilles":[481],"Salles.":[482],"Five-year":[483],"DLBCL:":[495],"Final":[496],"phase":[500],"[abstract].":[504],"In:":[505],"Proceedings":[506],"American":[509],"Association":[510],"Cancer":[512,532],"Research":[513],"Annual":[514],"Meeting":[515],"2023;":[516],"Part":[517],"2":[518],"(Clinical":[519],"Trials":[520],"Late-Breaking":[522],"Research);":[523],"2023":[524],"Apr":[525],"14-19;":[526],"Orlando,":[527],"FL.":[528],"Philadelphia":[529],"(PA):":[530],"AACR;":[531],"Res":[533],"2023;83(8_Suppl):Abstract":[534],"nr":[535],"CT022.":[536]},"counts_by_year":[{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-04-15T00:00:00"}